These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30572158)

  • 21. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.
    Tian Y; Qi J; Zhang W; Cai Q; Jiang X
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12038-45. PubMed ID: 25050635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability and Antimicrobial Activity of Nisin-Loaded Mesoporous Silica Nanoparticles: A Game-Changer in the War against Maleficent Microbes.
    Behzadi F; Darouie S; Alavi SM; Shariati P; Singh G; Dolatshahi-Pirouz A; Arpanaei A
    J Agric Food Chem; 2018 Apr; 66(16):4233-4243. PubMed ID: 29621394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
    Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
    J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.
    Li LL; Wang H
    Adv Healthc Mater; 2013 Oct; 2(10):1351-60. PubMed ID: 23526816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatibility of mesoporous silica nanoparticles.
    Asefa T; Tao Z
    Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
    Galhano J; Marcelo GA; Duarte MP; Oliveira E
    Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Inhibition of Drug-Resistant
    Ye Z; Wang S; Xu Y; Zhang J; Yan W
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid Nanoparticles and Composite Hydrogel Systems for Delivery of Peptide Antibiotics.
    Iudin D; Vasilieva M; Knyazeva E; Korzhikov-Vlakh V; Demyanova E; Lavrentieva A; Skorik Y; Korzhikova-Vlakh E
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.
    Otto RG; van Gorp E; Kloezen W; Meletiadis J; van den Berg S; Mouton JW
    Int J Antimicrob Agents; 2019 Jan; 53(1):34-39. PubMed ID: 30240838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
    Choi E; Lim DK; Kim S
    J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver Nanoparticles.
    Jasim R; Schneider EK; Han M; Azad MAK; Hussein M; Nowell C; Baker MA; Wang J; Li J; Velkov T
    J Biomed Nanotechnol; 2017 Apr; 13(4):447-57. PubMed ID: 29384621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Study on Photodynamic Activation of Ortho-Toluidine Blue and Methylene Blue Loaded Mesoporous Silica Nanoparticles Against Resistant Microorganisms.
    Amin A; Kaduskar DV
    Recent Pat Drug Deliv Formul; 2018; 12(3):154-161. PubMed ID: 29952275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrospinning of silica nanoparticles-entrapped nanofibers for sustained gentamicin release.
    Chen X; Xu C; He H
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1085-1089. PubMed ID: 31279530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.